Revision arthroplasty
Revision arthroplasty has been studied in 7 papers since 2024: 7 observational studies in people; 4 in the past year. The newest paper, Oct 15, 2026: “How have management and outcomes of periprosthetic proximal femoral fractures changed? A comparison of two 8 year time periods in a high volume centre”.
7 papers study it2 findingsUpdated
1 new paper in 30 daysSee all 7
“revision (OR 0.78, 95% CI 0.68 to 0.91) were associated with lower 30-day mortality”
None of its findings points the other way.
- 2 independent labs in 2 countries
- Funders: AO Foundation and 7 more
- Humans7
What is Revision arthroplasty linked with?
2Studies link Revision arthroplasty with 2 measures, most often dislocation rate (1 study) and 30-day mortality (1).
Dislocation rate
upin humans1
1 study
Dislocation rate
upin humans1
Revision arthroplasty raises the risk of dislocation rate in humans (p = 0.001).
“dislocation rate was higher in the revision group (p = 0.001)”
HumansB2-B3 FH-PPFn = 485
Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology
30-day mortality
downin humans1OR 0.78
1 study
30-day mortality
downin humans1OR 0.78
Revision arthroplasty lowers the risk of 30-day mortality in humans (OR 0.78, 95% CI 0.68 to 0.91).
“revision (OR 0.78, 95% CI 0.68 to 0.91) were associated with lower 30-day mortality”
Humanspostoperative periprosthetic femoral fracturen = 33,728
Bone & joint open